19 mayo 2015
Scientists are reporting development of a new way to modify interleukin-2 (IL-2), a substance known as a cytokine that plays key roles in regulating immune system responses, in order to fine-tune its actions. Harnessing the action of IL-2 in a controllable fashion is of clinical interest with potential benefit in a range of situations, including transplantation and autoimmune disease.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/AL3iqnyq_f0/150519132633.htm
